Panzomic 40
Pantoprazole Sodium IP equivalent to Pantoprazole 40 mg
Rx GastroenterologyOndimist 2ml Injection
Ondimist 2ml Injection
Ondansetron Hydrochloride Dihydrate 2 mg/ml
2 mg/ml (2 ml ampoule)
Indications
- Prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy
- Prevention and treatment of radiotherapy-induced nausea and vomiting
- Prevention and treatment of post-operative nausea and vomiting
- Patients who cannot retain or absorb an oral antiemetic
Contraindications
- Known hypersensitivity to ondansetron or to other selective 5-HT3 receptor antagonists
- Concomitant use with apomorphine, with which profound hypotension and loss of consciousness have been reported
- Congenital long QT syndrome
- Caution with uncorrected electrolyte disturbance, bradyarrhythmia, or other medicines that prolong the QT interval
Side effects
- Headache, flushing or a sensation of warmth
- Constipation
- Pain, redness or burning at the injection site
- Transient rise in liver aminotransferases, dose-related QT prolongation and, rarely, hypersensitivity reactions
Important: This information is provided for educational purposes only and is not a substitute for professional medical advice. Please consult a Registered Medical Practitioner before starting, stopping, or changing any medication. Manufactured and marketed under Indian DCGI regulations.
Product information sheet
Frequently asked questions
What is Ondimist 2ml Injection used for?
Ondimist 2ml Injection is used to prevent and treat nausea and vomiting caused by cytotoxic chemotherapy and radiotherapy, and to prevent and treat post-operative nausea and vomiting. It is given by a healthcare professional as directed by the treating physician.
Is Ondimist Injection the same as ondansetron?
Yes – Ondimist is Allomedix Healthcare's brand of ondansetron. The injection contains ondansetron hydrochloride dihydrate at 2 mg per ml in a 2 ml ampoule, so a prescription written for either the brand or the molecule refers to the same active drug.
Who should not be given Ondimist Injection?
It should not be given to anyone with a known hypersensitivity to ondansetron or another 5-HT3 antagonist, to patients taking apomorphine, or to patients with congenital long QT syndrome. Caution is also needed where electrolytes are disturbed or other QT-prolonging drugs are in use.
Related Products
More from the same therapeutic area.